J. B. Chemicals & Pharmaceuticals Future Growth
Future criteria checks 4/6
J. B. Chemicals & Pharmaceuticals is forecast to grow earnings and revenue by 19.4% and 12.8% per annum respectively. EPS is expected to grow by 19.4% per annum. Return on equity is forecast to be 22.1% in 3 years.
Key information
19.4%
Earnings growth rate
19.4%
EPS growth rate
Pharmaceuticals earnings growth | 17.8% |
Revenue growth rate | 12.8% |
Future return on equity | 22.1% |
Analyst coverage | Good |
Last updated | 09 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 51,190 | 9,990 | 6,916 | 10,684 | 12 |
3/31/2026 | 45,566 | 8,601 | 7,687 | 9,249 | 14 |
3/31/2025 | 40,336 | 7,074 | 6,517 | 7,863 | 14 |
9/30/2024 | 37,113 | 6,111 | 5,317 | 7,451 | N/A |
6/30/2024 | 35,924 | 5,871 | N/A | N/A | N/A |
3/31/2024 | 34,842 | 5,526 | 5,316 | 7,890 | N/A |
12/31/2023 | 33,848 | 5,141 | N/A | N/A | N/A |
9/30/2023 | 33,330 | 4,866 | 2,888 | 7,680 | N/A |
6/30/2023 | 32,607 | 4,471 | N/A | N/A | N/A |
3/31/2023 | 31,493 | 4,098 | -1,291 | 6,286 | N/A |
12/31/2022 | 30,115 | 4,071 | N/A | N/A | N/A |
9/30/2022 | 28,195 | 3,848 | -7,379 | 3,122 | N/A |
6/30/2022 | 26,031 | 3,715 | N/A | N/A | N/A |
3/31/2022 | 24,242 | 3,854 | -5,367 | 1,701 | N/A |
12/31/2021 | 23,281 | 4,011 | N/A | N/A | N/A |
9/30/2021 | 22,757 | 4,713 | 3,154 | 3,745 | N/A |
6/30/2021 | 21,262 | 4,474 | N/A | N/A | N/A |
3/31/2021 | 20,425 | 4,480 | 2,670 | 3,148 | N/A |
12/31/2020 | 19,576 | 3,975 | N/A | N/A | N/A |
9/30/2020 | 18,381 | 3,097 | 1,178 | 1,786 | N/A |
6/30/2020 | 18,509 | 3,295 | N/A | N/A | N/A |
3/31/2020 | 17,747 | 2,720 | 2,028 | 2,757 | N/A |
12/31/2019 | 17,501 | 2,686 | N/A | N/A | N/A |
9/30/2019 | 17,035 | 2,521 | 2,148 | 2,749 | N/A |
6/30/2019 | 16,824 | 2,098 | N/A | N/A | N/A |
3/31/2019 | 16,432 | 1,935 | 1,452 | 1,943 | N/A |
3/31/2018 | 14,084 | 1,383 | N/A | 1,229 | N/A |
3/31/2017 | 13,443 | 1,841 | N/A | 2,011 | N/A |
3/31/2016 | 12,104 | 1,625 | N/A | 1,404 | N/A |
3/31/2015 | 11,442 | 1,004 | N/A | 1,267 | N/A |
3/31/2014 | 10,219 | 615 | N/A | -140 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 506943's forecast earnings growth (19.4% per year) is above the savings rate (6.7%).
Earnings vs Market: 506943's earnings (19.4% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: 506943's earnings are forecast to grow, but not significantly.
Revenue vs Market: 506943's revenue (12.8% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: 506943's revenue (12.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 506943's Return on Equity is forecast to be high in 3 years time (22.1%)